Literature DB >> 8240819

Huntington's disease gene (IT15) is widely expressed in human and rat tissues.

S H Li1, G Schilling, W S Young, X J Li, R L Margolis, O C Stine, M V Wagster, M H Abbott, M L Franz, N G Ranen.   

Abstract

Huntington's Disease (HD) is notable for selective neuronal vulnerability in the basal ganglia and cerebral cortex. We have investigated in human and rodent tissues the expression of the gene (IT15) whose mutation causes HD. IT15 is widely expressed, with highest levels of expression in brain, but also in lung, testis, ovary, and other tissues. Within the brain, expression is widespread with a neuronal pattern and is not enriched in the basal ganglia. Expression of IT15 is not reduced in the brain of HD patients when corrected for actin (though it is slightly decreased in the striatum when uncorrected, consistent with neuronal loss). Thus, the widespread distribution of IT15 expression does not correspond with the restricted distribution of neuropathologic changes in HD. We suggest that pathophysiology may relate to abnormal cell type-specific protein interactions of the HD protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240819     DOI: 10.1016/0896-6273(93)90127-d

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  97 in total

1.  Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice.

Authors:  J A Bibb; Z Yan; P Svenningsson; G L Snyder; V A Pieribone; A Horiuchi; A C Nairn; A Messer; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

Review 3.  Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.

Authors:  Ina Han; YiMei You; Jeffrey H Kordower; Scott T Brady; Gerardo A Morfini
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

4.  Effects of mutant huntingtin on mGluR5-mediated dual signaling pathways: implications for therapeutic interventions.

Authors:  Shan-Shan Huang; Jun He; Dong-Ming Zhao; Xiao-Yuan Xu; Hui-Ping Tan; He Li
Journal:  Cell Mol Neurobiol       Date:  2010-07-20       Impact factor: 5.046

5.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

6.  Somatic mosaicism of expanded CAG repeats in brains of patients with dentatorubral-pallidoluysian atrophy: cellular population-dependent dynamics of mitotic instability.

Authors:  H Takano; O Onodera; H Takahashi; S Igarashi; M Yamada; M Oyake; T Ikeuchi; R Koide; H Tanaka; K Iwabuchi; S Tsuji
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

7.  Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy.

Authors:  Robert G Mealer; Alexandra J Murray; Neelam Shahani; Srinivasa Subramaniam; Solomon H Snyder
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

Review 8.  A role for autophagy in Huntington's disease.

Authors:  Katherine R Croce; Ai Yamamoto
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

Review 9.  A cellular perspective on conformational disease: the role of genetic background and proteostasis networks.

Authors:  Tali Gidalevitz; Elise A Kikis; Richard I Morimoto
Journal:  Curr Opin Struct Biol       Date:  2010-01-05       Impact factor: 6.809

10.  Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.

Authors:  J Bao; A H Sharp; M V Wagster; M Becher; G Schilling; C A Ross; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.